Cilostazol

Basic Cilostazol Information

• INN (International Nonproprietary Name): Cilostazol.
• Brand Names Available In Australia: Pletal 100 mg tablets, bottle 56.
• ATC Code: B01AC23.
• Forms & Dosages: Film-coated tablets 100 mg and 50 mg in blisters or bottles (common pack sizes include 10, 14, 30, 56, 60, 100).
• Manufacturers In Australia: Otsuka and Accord Healthcare are listed among global suppliers; local supply may be via these distributors.
• Registration Status In Australia: TGA approved for intermittent claudication / peripheral arterial disease.
• OTC / Rx Classification: Prescription only (Rx) in Australia.

Critical Warnings & Restrictions

High-Risk Groups

Who should not take cilostazol without specialist input?

• Absolute contraindications: any degree of congestive heart failure, pregnancy, severe hepatic impairment, active bleeding, known allergy to cilostazol or excipients.
• Severe renal impairment: use is not recommended.
• Elderly patients: no routine initial dose reduction, but closer monitoring is advised because of higher risk of tachycardia, dizziness and falls.
• Ischaemic heart disease, arrhythmias, uncontrolled hypertension or bleeding disorders: require specialist review before starting.

Pre-Start Screening Checklist:

• Confirm cardiac history, including any heart failure or arrhythmia.
• Check recent ECG if cardiovascular disease is present.
• Check baseline liver function tests (LFTs) and renal function.
• Review current medications for antiplatelet or anticoagulant use.
• Assess pregnancy status in women of childbearing potential.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Will cilostazol affect driving and safety-critical work?

Cilostazol commonly causes headache, dizziness and palpitations.

These adverse effects can impair driving or operation of heavy machinery.

• Do not drive or operate heavy machinery until you know how cilostazol affects you.
• Report any syncope, severe dizziness or palpitations to your prescriber immediately.
• For commercial drivers and safety-sensitive roles, consult employer occupational health and retain documentation of prescriber advice.

Patient Checklist (Printable):

• Do not drive until tolerated.
• Stop and sit down if dizziness or lightheadedness occurs.
• Report fainting, palpitations or chest pain immediately.
• Inform your employer if you hold a commercial driving or safety-critical role.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: Not until you know how cilostazol affects you.

Common adverse effects include headache, dizziness and tachycardia.

If you are a commercial driver, notify your treating clinician and employer as Australian workplace rules may require restrictions or medical certification.

Usage Basics

INN, Brand Names Available In Australia

What names will you see on the script or pack?

Legal Classification (TGA‑Approved, PBS Context)

Cilostazol is a prescription-only medicine in Australia and is TGA approved for intermittent claudication due to peripheral arterial disease.

PBS subsidy status may change over time, so check the PBS Schedule for current listings and any authority criteria.

1. TGA Approval: Product registration and approved indications recorded by the Therapeutic Goods Administration.
2. PBS Listing: A separate process; a medicine can be TGA approved but not PBS listed, or have authority requirements for subsidy.

Useful Links:

• Therapeutic Goods Administration (TGA) website
• PBS search and Schedule

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Typical adult dosing for intermittent claudication is straightforward.

• Adult dose: 100 mg orally twice daily.
• Timing: Take at least 30 minutes before breakfast and 30 minutes before dinner to optimise absorption and efficacy.
• Onset: Symptom improvement is gradual and may take several weeks; full benefit can take up to 12 weeks.
• Stopping Rule: If no benefit after 3 months, discontinue and reassess therapy.

Timeline Graphic (Text Version):

• Week 0: Start cilostazol 100 mg twice daily.
• Weeks 2–4: Some patients notice early walking-distance gains.
• Weeks 8–12: Full symptomatic benefit may be reached.
• Month 3: Review — stop if no meaningful benefit.

Adjustments For Comorbidities

Who needs dose changes or extra checks?

• Children: Not recommended — safety and efficacy not established.
• Elderly: Generally no initial dose reduction, but monitor for dizziness, tachycardia and falls.
• Hepatic Impairment: Contraindicated in moderate to severe hepatic impairment.
• Renal Impairment: Use with caution in mild–moderate impairment; avoid in severe impairment.
• Concomitant Antithrombotic Therapy: Shared monitoring plan for bleeding signs and haemoglobin is required when used with anticoagulants or additional antiplatelets.

Dose Adjustment And Monitoring Checklist:

• Baseline LFTs and periodic monitoring for hepatic concerns.
• Baseline renal function and review in renal impairment.
• Obtain ECG if history of arrhythmia or ischaemic heart disease.
• Arrange follow-up for bleeding surveillance if on antiplatelet/anticoagulant therapy.

Q&A — “What If I Miss A Dose?”

If you miss a dose, take it as soon as you remember unless it is close to the next scheduled dose.

Do not double the dose to make up for a missed tablet.

For overdose or repeated extra doses, seek urgent medical attention and watch for tachycardia, hypotension or arrhythmias.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Are there foods or drinks to avoid?

There are no strict food restrictions for cilostazol.

Moderate alcohol intake is advisable because alcohol can worsen dizziness or hypotension when combined with vasodilatory medicines.

Caffeine or typical Australian diets do not have direct contraindications with cilostazol but monitor symptoms like palpitations which caffeine may exacerbate.

Common Drug Conflicts

Which drugs interact with cilostazol and what to do?

Cilostazol is metabolised primarily by CYP3A4 and CYP2C19, so inhibitors of these enzymes can increase cilostazol levels.

Stop/Start Flags:

• Stop and seek review if starting a strong CYP3A4 or CYP2C19 inhibitor.
• Start monitoring if initiating anticoagulant or additional antiplatelet therapy.
• Consider ECG before combining with drugs known to affect cardiac rhythm.

User Reports & Trends (Australian Patient Feedback)

What are Australian patients saying in forums, ProductReview and pharmacy counselling?

• Pros: Many patients report improved walking distance over weeks when used for intermittent claudication.
• Cons: Commonly reported side effects include headache, diarrhoea, palpitations, dizziness and peripheral oedema.
• Timing: Several users note benefits beginning after a few weeks and clearer improvement by 8–12 weeks.

Anonymised Patient Quotes:

• “I noticed I could walk a little further after about a month.”
• “Bad headaches at first but they eased after a couple of weeks.”
• “My GP checked my heart before starting because I have palpitations.”

Keep in mind selection and reporting bias on public forums, and triangulate patient reports with clinical trial data and TGA product information for balanced counselling.

Access & Purchase Options (Australia)

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Where can Australians get cilostazol filled?

Note: Cilostazol is prescription only and major chains will dispense on receipt of a valid prescription.

In our online pharmacy, cilostazol is dispensed on prescription and discreet delivery across Australia is offered with normal courier timelines.

Online Pharmacies And Telehealth E‑Prescriptions

How to avoid scams and ensure safe online ordering.

• Confirm pharmacy registration and accreditation before ordering.
• Ensure identity verification and that prescriptions comply with Australian regulations.
• Telehealth plus e-prescriptions are useful for rural patients needing access to specialists and prescriptions.
• Check packaging and courier handling instructions for hot or humid conditions when tablets are mailed.

Telehealth Flow (Text):

• Telehealth consult → Electronic prescription issued → Pharmacy receives e-prescription → Dispensing and courier delivery.

Mechanism & Pharmacology

Simplified Explanation

How does cilostazol work in plain language?

Mechanism

Cilostazol is a phosphodiesterase III inhibitor that raises intracellular cAMP in platelets and vascular smooth muscle.

Onset

Symptomatic benefit is gradual and may take several weeks, up to 12 weeks for full effect.

Indication

Used to improve walking distance in patients with intermittent claudication due to peripheral arterial disease; not for acute ischaemic events.

Clinical Terms (PK/PD Highlights)

Key pharmacology facts to share with clinicians and informed patients.

Glossary

PK = pharmacokinetics; PD = pharmacodynamics; cAMP = cyclic adenosine monophosphate; PDE‑III = phosphodiesterase III.

Indications & Off‑Label Uses

Approved Indications By TGA

TGA aligns with international approvals for cilostazol.

• Indication: Symptomatic intermittent claudication due to peripheral arterial disease.
• Expected Benefit Timeline: Some improvement by weeks, full benefit by up to 12 weeks.
• Stopping Rules: Discontinue if no meaningful improvement after 3 months.

Off‑Label Uses In Australian Clinical Practice

Is off‑label use common?

Off‑label use is uncommon and should be reserved for specialist-led care with documented rationale.

Examples are limited and typically involve multidisciplinary vascular rehabilitation rather than standalone use.

Off‑Label Prescribing Documentation Checklist:

• Record clinical rationale and evidence summary.
• Obtain and document patient informed consent.
• Arrange specialist follow-up and monitoring plan.

Key Clinical Findings (Evidence Synthesis)

What do major trials and reviews say about cilostazol?

• Cilostazol provides a mean improvement in walking distance in patients with intermittent claudication, often evident within weeks and maximal by 12 weeks.
• Safety signals include increased heart rate, headache and gastrointestinal symptoms; heart failure remains an important contraindication.
• Regulatory product information from TGA, EMA and FDA summarises similar efficacy and safety findings across jurisdictions.

Recommended Citations: TGA product information and major systematic reviews available in vascular medicine literature.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Pros And Cons Checklist

Use this checklist to decide between cilostazol and alternatives.

• Expected walking benefit versus timeline for improvement.
• Cardiovascular comorbidity and absolute contraindications such as heart failure.
• Drug interactions and tolerance of side effects like headache or palpitations.
• PBS affordability and availability of supervised exercise programmes.

Common Questions (Pharmacy Consultations)

Short pharmacist scripts for frequent queries.

• Q: Is it safe with my aspirin? — A: It can be used with single antiplatelet therapy but multiple antithrombotics increase bleeding risk; arrange a medication review and monitor for bleeding.
• Q: How long until I notice improvement? — A: Some patients notice change within weeks; evaluate after 3 months and stop if no benefit.
• Q: Can I have this while pregnant? — A: No — pregnancy is a contraindication; seek specialist advice for alternatives.
• Q: Should I stop if I get palpitations? — A: Report palpitations immediately; if severe or associated with syncope or chest pain, seek urgent medical attention.

Printable Counselling Card For Pharmacists:

• Confirm prescription and indication.
• Explain dosing: 100 mg twice daily, 30+ minutes before meals.
• Review contraindications and interactions.
• Advise on driving and work safety.
• Arrange follow-up and monitoring plan.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Note: Prices fluctuate and PBS concession cards may reduce out‑of‑pocket costs. Always check the PBS website for current subsidy status before advising patients.

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

• Call ahead to confirm local stock or request backorder.
• Use telehealth for e‑prescriptions if travel or specialist access is limited.
• Consider courier timelines for rural deliveries and insulated packaging in hot weather.
• Ask about generic options to reduce cost and check concession entitlements on PBS.

Registration & Regulation

TGA Approval

Cilostazol is registered with the Therapeutic Goods Administration for intermittent claudication / peripheral arterial disease.

Key label cautions include contraindication in any heart failure and moderate‑to‑severe hepatic impairment.

Link Recommendation: Refer to the TGA ARTG entry for the specific brand for up‑to‑date product information.

PBS Subsidy Details

PBS listing and subsidy rules change periodically and may require authority prescriptions in some circumstances.

Step‑By‑Step Checklist To Verify PBS Eligibility:

• Search the PBS Schedule for the medicine name and brand.
• Check for any authority approval or clinical criteria required for subsidy.
• Confirm concession card status and safety‑net thresholds for the patient.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

How should patients store cilostazol at home?

• Store below 25°C and protect from moisture and light.
• Keep tablets in the original packaging and away from bathrooms where humidity is high.
• In hot Australian summers, store in a cool, shaded cupboard or climate‑controlled area.
• Keep out of reach of children and pets.

Cold‑Chain Handling For Pharmacies

Pharmacies do not require cold‑chain for cilostazol but should avoid prolonged heat exposure.

• Follow TGA supply chain guidance and document storage temperatures.
• Record batch and dispensing details in the pharmacy records.
• When mailing to remote areas advise on insulated packaging during summer months.

Guidelines For Proper Use (Clinical & Counselling)

Australian Pharmacist Counselling Style

Short, practical counselling script for dispensing staff.

• Confirm indication: symptomatic intermittent claudication.
• Explain dosing: 100 mg twice daily, at least 30 minutes before breakfast and dinner.
• Set expectations: some improvement over weeks; review at 3 months and stop if no benefit.
• Explain common side effects: headache, diarrhoea, palpitations, dizziness and peripheral oedema.
• Advise urgent review for chest pain, syncope or severe palpitations.
• Encourage supervised exercise therapy in addition to medication.

Provide a printable one‑page patient handout summarising the above points and safety actions.

Patient Advice From PBS And National Health Authorities

Where should patients look for authoritative information?

• Check TGA and PBS resources for current regulatory and subsidy information.
• Use accredited telehealth and registered pharmacies for continuity of care.
• Keep a symptom diary to record walking distance and adverse events for review visits.

When To Seek Help Flowchart (Text):

• New severe chest pain or syncope → Seek emergency care (call 000).
• Severe palpitations or persistent dizziness → Contact GP or emergency department.
• Mild side effects that persist or worsen → Contact pharmacist or prescriber for review.

Delivery Across Australia